Key Market Segments:
By Product
-
-
Solutions
-
Integrated Solutions
-
Standalone Solutions
-
-
Services
-
Support
-
Implementation
-
Training
-
Network
-
-
By Delivery Mode
-
-
Web/Cloud-Based
-
On Premise
-
By Usage Methods
-
-
Handheld
-
Computer-Based Devices
-
By Substances
-
-
Controlled Substances
-
Non-controlled Substances
-
By Specialties
-
-
Oncology
-
Sports Medicine
-
Neurology
-
Cardiology
-
Others
-
By End-Use
-
-
Hospital
-
Office-based Physicians
-
Pharmacy
-
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated the E-Prescribing Market in 2024.
The e-prescribing market companies are Allscripts Healthcare Solutions (Veradigm), Surescripts, Epic Systems, Cerner Corporation (Oracle), DrFirst, eClinicalWorks, NextGen Healthcare, Athenahealth, MEDITECH, RXNT, and other players.
Government Mandates and Regulatory Support Lead to Market Growth.
The E-Prescribing Market was USD 3.59 billion in 2024 and is expected to reach USD 23.34 billion by 2032.
The E-Prescribing Market is expected to grow at a CAGR of 25.39% from 2025 to 2032.